Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
339M
-
Number of holders
-
122
-
Total 13F shares, excl. options
-
137M
-
Shares change
-
-3.33M
-
Total reported value, excl. options
-
$183M
-
Value change
-
-$9.24M
-
Put/Call ratio
-
0
-
Number of buys
-
61
-
Number of sells
-
-44
-
Price
-
$1.34
Significant Holders of Nuvation Bio Inc. - Common Stock (NUVB) as of Q3 2023
135 filings reported holding NUVB - Nuvation Bio Inc. - Common Stock as of Q3 2023.
Nuvation Bio Inc. - Common Stock (NUVB) has 122 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 137M shares
of 339M outstanding shares and own 40.36% of the company stock.
Largest 10 shareholders include FMR LLC (32.7M shares), EcoR1 Capital, LLC (19.2M shares), Omega Fund Management, LLC (15.1M shares), BlackRock Inc. (13.2M shares), Deep Track Capital, LP (7.72M shares), VANGUARD GROUP INC (7.3M shares), ABRAMS CAPITAL MANAGEMENT, L.P. (3.81M shares), Redmile Group, LLC (3.03M shares), STATE STREET CORP (3.03M shares), and GEODE CAPITAL MANAGEMENT, LLC (2.9M shares).
This table shows the top 122 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.